6 Stocks That Fell Off Hard in 2025

Six formerly high‑profile names posted steep 12‑month declines driven by sector-specific pain and macro headwinds: Enphase (≈$95→$37, ~‑60%) hit by slower solar demand, higher rates and oversupply; Nike (≈$80→$69, ~‑14%) weighed by softer consumer spending, weak China sales and tariff worries; Sarepta (≈$120→$22, ~‑82%) collapsed after disappointing trials and regulator safety concerns. Peloton (≈$10→$7.60, ~‑24%) faces waning demand and subscription shortfalls, Plug Power (≈$6.80→$2.40, ~‑65%) suffered cash burn and dilution, and Rivian (≈$20→$9.50, ~‑52%) continues to struggle with production costs, profitability and trade/tariff tensions — a cross‑section of earnings, demand and policy risks that should recalibrate risk premia for exposed sectors.

Analysis

Market structure: The hits to ENPH, PLUG, RIVN and SRPT reflect a classic rotation away from high-volatility, cap-intensive growth into cash-generative incumbents and defensives; winners are low-cost manufacturers, cash-flowing consumer names and commodity shorts (polysilicon/lithium). Oversupply in solar/hydrogen and slowing EV demand compress pricing power — expect 4–8 quarters of margin pressure and inventory digestion, with Chinese low-cost producers taking share where scale matters.

Risk assessment: Tail risks include a negative FDA decision for SRPT (binary, could move shares ±50–80% in 0–90 days), tariff escalation hitting NKE/RIVN (10–25% P&L shock), or a funding winter forcing PLUG into distressed equity issuance or restructuring within 6–12 months. Near-term (days–weeks) volatility will cluster around earnings, FDA readouts and tariff announcements; medium-term (3–9 months) outcomes hinge on inventory draws and funding access, long-term (12–36 months) depends on structural demand and technology adoption curves.

Trade implications: Favor conviction shorts in capital-intensive, cash-burning names and selective longs in cash-generative consumer staples; implement capital-efficient options for binary risks (buy puts on SRPT for 30–90 days, put spreads on ENPH for 3–6 months). Use pair trades to neutralize macro (long NKE vs short RIVN to express durable consumer outperformance vs EV capex stress); rebalance sector exposure by reducing renewable/hydrogen hardware beta by 30–50%.

Contrarian angles: Consensus prices in persistent demand collapse, which may be overstated if rates peak and policy support returns (e.g., 10y yield drop >50bp or new subsidies), creating 40–100% rebounds in select beaten-down equity. Watch for consolidation opportunities (M&A in solar/hydrogen) and short-squeeze risk in heavily shorted names; historically, 12–24 month rebounds have followed industry consolidation after capacity rationalization.

Key Decisions for Investors

• Establish a 2.5% portfolio short in ENPH via a 3–6 month bear put spread (buy $40 / sell $30 or nearest strikes) if shares remain below $50; take profits at 35–50% or cut loss if ENPH closes above $60 for 5 consecutive trading days.
• Initiate a 2% tactical long in NKE on a pullback to $65 (or add up to 1.5% if China revenue sequentially stabilizes), target 12-month upside to $85; fund by reducing exposure to PLUG/ENPH by 50% of current weights.
• Buy SRPT 60–120 day puts sized to 1.5% portfolio risk ahead of any FDA/regulatory calendar (monitor advisory dates next 30–60 days); if negative readout occurs, scale to 3% and target 50–80% option P&L, if positive close positions immediately.
• Implement a pair trade: long NKE (1.5%) vs short RIVN (1.5% equity) to express consumer resilience vs EV capex risk; enter if spread (NKE total return minus RIVN) narrows by >5% in 30 days, exit or rebalance on mean reversion or if RIVN posts two consecutive quarters of positive free cash flow guidance.